NEFL and Alzheimer disease: However, the most promising application of plasma NfL is in evaluating treatment response in AD, as seen in multiple sclerosis studies (Novakova et al. 2017), as recent animal studies using β-secretase inhibitors have shown reduction in plasma NfL (Bacioglu et al. 2016).